Abstract
To determine if bone morphogenetic protein-2 (BMP-2) can induce the endochondral maturation of resting zone (RC) chondrocytes, confluent fourth-passage cultures of these cells were pretreated for 24, 36, 48, 72, or 120 h with recombinant human BMP-2. At the end of pretreatment, the media were replaced with new media containing 10−10–10−8 M 1,25-(OH)2D3 or 10−9–10−7 M 24,25-(OH2)D3, and the cells incubated for an additional 24 h. This second treatment was chosen, because prior studies had shown that the more mature growth zone (GC) chondrocytes and RC cells respond to 1,25-(OH)2D3 and 24,25-(OH)2D3 in distinctly different ways with respect to the parameters examined. The effect of BMP-2 pretreatment on cell maturation was assessed by measuring alkaline phosphatase specific activity (ALPase). In addition, changes in matrix protein production were assessed by measuring collagen synthesis, as well as [35S]-sulfate incorporation into proteoglycans. When RC cells were pretreated for 72 or 120 h with BMP-2, treatment with 1,25-(OH)2D3 caused a dose-dependent increase in ALPase specific activity and collagen synthesis, with no effect on proteoglycan sulfation. RC cells pretreated with 1,25-(OH)2D3 responded like RC cells that had not received any pretreatment. RC cells normally respond to 24,25-(OH)2D3; however, RC cultures pretreated for 72 or 120 h with BMP-2 lost their responsiveness to 24,25-(OH)2D3. These results indicate that BMP-2 directly regulates the differentiation and maturation of RC chondrocytes into GC chondrocytes. These observations support the hypothesis that BMP-2 plays a significant role in regulating chondrocyte maturation during endochondral ossification.
Similar content being viewed by others
References
Boskey, A. L. (1981). Clin. Orthop. Related Res. 157, 225–257.
Howell, D. S. and Dean, D. D. (1992). In: Disorders of bone and mineral metabolism. Coe, F. L. and Favus, M. J., eds., Raven, New York, pp. 313–353.
Urist, M. R. (1965). Science 150, 893–899.
Lee, M. B. (1997). J. Clin. Periodontol. 24, 355–365.
Reddi, A. H. and Anderson, W. A. (1976). J Cell Biology 69, 557–572.
Boyan, B. D., Schwartz, Z., Swain, L. D., Khare, A. G., Heckman, J. D., Ramirez, V., et al. (1992). Clin. Orthop. 278, 286–304.
Chen, P., Carrington, J. L., Hammonds, R. G., and Reddi, A. H. (1991). Exp. Cell. Res. 195, 509–515.
Rosen, V., Capparella, J., McQuaid, D., Cox, K., Thies, R. S., Song, J., et al. (1993). Prog. Clin. Biol.Res. 383A, 305–315.
Sato, K. and Urist, M. R. (1984). Clin. Orthop. Related Res. 183, 180–187.
Wang, E. A., Israel, D. I., Kelly, S., and Luxenberg, D. P. (1993). Growth Factors 9, 57–71.
Yamaguchi, A., Ikeda, T., Katagiri, T., Suda, T., and Yoshiki, S. (1992). Bone Miner. 17S, 191.
Harris, S. E., Ghosh-Choudhury, N., Fuqua, S. A., Wolf, D., Harris, M. A., Feng, J. Q., et al. (1994). J. Bone Miner. Res. 9, S171.
Enomoto-Iwamoto, M., Iwamoto, M., Mukudai, Y., Kawakami, Y., Nohno, T., Higuchi, Y., et al. (1998). J. Cell. Biol. 140, 409–418.
Leboy, P. S., Sullivan, T. A., Nooreyazdan, M., and Venezian, R. A. (1997). J. Cell. Biochem. 66, 394–403.
Grimsrud, C. D., Rosier, R. N., Puzas, J. E., Reynolds, P. R., Reynolds, S. D., Hicks, D. G., et al. (1998). J. Orthop. Res. 16, 247–255.
Johansson, N., Saarialho-Kere, U., Airola, K., Herva, R., Nissinen, L., Westermarck, J., et al. (1997). Developmental Dynamics 208, 387–397.
Erickson, D. M., Harris, S. E., Dean, D. D., Harris, M. A., Wozney, J. M., Boyan, B. D., et al. (1997). J. Orthop. Res. 15, 371–380.
Linkhart, T. A., Mohan, S., and Baylink, D. J. (1996). Bone 19(Suppl.), 1S-12S.
Lyons, K. M., Pelton, R. W., and Hogan, B. L. (1989). Genes Dev. 3, 1657–1668.
Chang, S. C., Hoang, B., Thomas, J. T., Vukicevic, S., Luyten, F. P., Ryba, N. J., Kozak, C. A., et al. (1994). J. Biol. Chem. 269, 28,227–28,234.
Puleo, D. A. (1997). J. Cell. Physiol. 173, 93–101.
Chen, D., Harris, M. A., Rossini, G., Dunstan, C. R., Dallas, S. L., Feng, J. Q., et al. (1997). Calcif. Tissue Int. 60, 283–290.
Gabbitas, B. and Canalis, E. (1995). Endocrinology 136, 2397–2403.
Ong, J. L., Cardenas, H. L., Cavin, R., and Carnes, D. L., Jr. (1997). Int. J. Oral Maxillofac. Implants 12, 649–654.
Boyan, B. D., Schwartz, Z., Swain, L. D., Carnes, D. L., Jr., and Zislis, T. (1988). Bone 9, 185–194.
Boyan, B. D., Schwartz, Z., Carnes, D. L., Jr., and Ramirez, V. (1988). Endocrinology 122, 2851–2860.
Schwartz, Z. and Boyan, B. D. (1988). Endocrinology 122, 2191–2198.
Schwartz, Z., Schlader, D. L., Ramirez, V., Kennedy, M. B., and Boyan, B. D. (1989). J. Bone Miner. Res. 4, 199–207.
Schwartz, Z., Schlader, D. L., Swain, L. D., and Boyan, B. D. (1988). Endocrinology 123, 2878–2884.
Schwartz, Z., Knight, G., Swain, L. D., and Boyan, B. D. (1988). J. Biol. Chem. 263, 6023–6026.
Dean, D. D., Boyan, B. D., Muniz, O. E., Howell, D. S., and Schwartz, Z. (1996). Calcif. Tissue Int. 59, 109–116.
Langston, G. G., Swain, L. D., Schwartz, Z., Del Toro, F., Gomez, R., and Boyan, B. D. (1990). Calcif. Tissue Int. 47, 230–236.
Schwartz, Z., Langston, G. G., Swain, L. D., and Boyan, B. D. (1991). J. Bone Miner. Res. 6, 709–718.
Swain, L. D., Schwartz, Z., Caulfield, K., Brooks, B. P., and Boyan, B. D. (1993). Bone 14, 609–617.
Schwartz, Z., Swain, L. D., Kelly, D. W., Brooks, B. P., and Boyan, B. D. (1992). Bone 13, 395–401.
Schwartz, Z., Brooks, B. P., Swain, L. D., Del Toro, F., Norman, A. W., and Boyan, B. D. (1992). Endocrinology 130, 2495–2504.
Schwartz, Z., Dean, D. D., Walton, J. K., Brooks, B. P., and Boyan, B. D. (1995). Endocrinology 136, 402–411.
Boyan, B. D., Dean, D. D., Sylvia, V. L., and Schwartz, Z. (1997). In: Vitamin D, Feldman, D., Glorieux, F. H., and Pike, J. W. (eds.). Academic: San Diego, CA, pp. 395–421.
Boyan, B. D., Swain, L. D., Schwartz, Z., Ramirez, V., and Carnes, D. L., Jr. (1992). Clin. Orthop. 277, 266–276.
Schwartz, Z., Hancock, R. H., Dean, D. D., Brooks, B. P., Gomez, R., Boskey, A. L., et al. (1995). Endocrine 3, 351–360.
Schwartz, Z., Sylvia, V. L., Liu, Y., Dean, D. D., and Boyan, B. D. (1998). Bone, 23, 465–470.
Caplan, A. I. and Boyan, B. D. (1994). In: Bone 8. Mechanisms of Bone Development and Growth, Hall, B. K. (eds.). CRC: Boca Raton, pp. 1–46.
Khare, A. G., Engel, F. E., Swain, L. D., Fite, D., Lee, T., Martin, S., et al. (1989). J. Bone Miner. Res. 4, S130.
Rosen, D. M., Stempien, S. A., Thompson, A. Y., and Seyedin, S. M. (1988). J. Cell. Physiol. 134, 337–346.
Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). Nature 390, 467–471.
Kretzschmar, M., Doody, J., and Massague, J. (1997). Nature 389, 618–622.
Sylvia, V. L., Mackey, S., Schwartz, Z., Shuman, L., Gomez, R., and Boyan, B. D. (1994). J. Bone Miner. Res. 9, 1477–1487.
Newton, A. C. (1995). J. Biol. Chem. 270, 28,495–28,498.
Nishizuka, Y. (1995). FASEB J. 9, 484–496.
Schwartz, Z., Sylvia, V. L., Dean, D. D., and Boyan, B. D. (1996). Connect. Tissue Res. 35, 101–106.
Ripamonti, U., Duneas, N., van den Heever, B., Bosch, C., and Crooks, J. (1997). J. Bone Miner. Res. 12, 1584–1595.
Sylvia, V. L., Schwartz, Z., Ellis, E. B., Helm, S. H., Gomez, R., Dean, D. D., et al. (1996). J. Cell. Physiol. 167, 380–393.
Sylvia, V. L., Schwartz, Z., Schuman, L., Morgan, R. T., Mackey, S., Gomez, R., et al. (1993). J. Cell. Physiol. 157, 271–278.
Pedrozo, H. A., Boyan, B. D., Mazock, J., Dean, D. D., Gomez, R., and Schwartz, Z. (1998). Calcif. Tissue Int., in press.
Glansbeek, H. L., van Beuningen, H. M., Vitters, E. L., Morris, E. A., van der Kraan, P. M., and van den Berg, W. B. (1997). Arthritis Rheum. 40, 1020–1028.
Flechtenmacher, J., Huch, K., Thonar, E. J., Mollenhauer, J. A., Davies, S. R., Schmid, T. M., et al. (1996). Arthritis Rheum. 39, 1896–1904.
Rosen, V., Nove, J., Song, J. J., Thies, R. S., Cox, K., and Wozney, J. M. (1994). J. Bone Miner. Res. 9, 1759–1768.
Hale, L. V., Kemick, M. L., and Wuthier, R. E. (1986). J. Bone Miner. Res. 1, 489–495.
Bretaudiere, J. P. and Spillman, T. (1984). In: Methods of Enzymatic Analysis. Bergmeyer, H. U. (eds.). Verlag Chemica: Weinheim, pp. 75–92.
Peterkofsky, B. and Diegelmann, R. (1971). Biochemistry 10, 988–994.
Beresford, J. N., Gallagher, J. A., and Russell, R. G. G. (1986). Endocrinology 119, 1776–1785.
O’Keefe, R. J., Puzas, J. E., Brand, J. S., and Rosier, R. N. (1988). Endocrinology 122, 2953–2961.
Nasatzky, E., Schwartz, Z., Soskolne, W. A., Brooks, B. P., Dean, D. D., Boyan, B. D., et al. (1994). Endocr. J. 2, 207–215.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwartz, Z., Sylvia, V.L., Liu, Y. et al. Treatment of resting zone chondrocytes with bone morphogenetic protein-2 induces maturation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3 . Endocr 9, 273–280 (1998). https://doi.org/10.1385/ENDO:9:3:273
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:9:3:273